Home
Kp Tissue Inc
KP Tissue Releases Fourth Quarter and Full Year 2025 Financial Results
Business
Feb 18 2026
23 min read

KP Tissue Releases Fourth Quarter and Full Year 2025 Financial Results

news images

Strong financial and operational performance in 2025

MISSISSAUGA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2025 and full year 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.1% interest in Kruger Products.

Kruger Products Q4 2025 Business and Financial Highlights

  • Revenue was $560.1 million in Q4 2025 compared to $539.6 million in Q4 2024, an increase of $20.5 million or 3.8%.

  • Adjusted EBITDA1 was $84.2 million in Q4 2025 compared to $66.8 million in Q4 2024, an increase of 26.0%.

  • Net income was $23.4 million in Q4 2025 compared to a net loss of $13.7 million in Q4 2024, an increase of $37.1 million.

  • Declared a quarterly dividend of $0.18 per share to be paid on April 15, 2026.

Kruger Products Full Year 2025 Financial Highlights

  • Revenue was $2,203.4 million in Fiscal 2025 compared to $2,049.9 million in Fiscal 2024, an increase of $153.5 million or 7.5%.

  • Adjusted EBITDA1 was $318.2 million in Fiscal 2025 compared to $264.8 million in Fiscal 2024 an increase of 20.2%.

  • Net income was $75.5 million in Fiscal 2025 compared to $23.8 million in Fiscal 2024, an improvement of $51.7 million.

“Fiscal 2025 proved to be a strong year across many areas of our business, marked by share gains and revenue growth, higher margins and greater profitability, along with enhanced operational efficiency and an improved safety record,” stated Kruger Products and KP Tissue’s Chief Executive Officer, Dino Bianco. “We are particularly pleased revenue growth was well-diversified both in Canada, leveraging our leadership position in this mature market, and in the U.S., serving as our growth engine for years to come.

“In fact, we are firming up the location, project scope and financial details of a new through-air-dried (TAD) facility slated to open in the western United States in 2028 with an official announcement expected in the first half of 2026.

“In the fourth quarter of 2025, our momentum culminated with Adjusted EBITDA growing 26.0% year-over-year to $84.2 million, mainly driven by higher sales volume. In addition, expanded in-sourcing of paper from our Sherbrooke Expansion Project improved the margins of our Away-From-Home segment and overall business.

“Going forward, we intend to build on our solid foundation, entrenched by three consecutive years of increases in revenue and profitability, to deliver growth in 2026 and beyond,” Mr. Bianco added.

Outlook for Q1 2026
For the first quarter of 2026, we expect Adjusted EBITDA1 to be in the range of Q4 2025.

Kruger Products Q4 2025 Financial Results
Revenue was $560.1 million in Q4 2025 compared to $539.6 million in Q4 2024, an increase of $20.5 million or 3.8%. The increase in revenue was primarily due to higher sales volume across both segments.

Cost of sales was $451.9 million in Q4 2025 compared to $459.3 million in Q4 2024, a decrease of $7.4 million or 1.6%. The decrease in cost of sales was primarily due to lower pulp prices compared to the year ago quarter and favourable productivity across our manufacturing sites, partially offset by higher sales volume and additional manufacturing overhead spend to invest in our sites. Freight rates were lower compared to Q4 2024 while warehousing expenses remained essentially flat. As a percentage of revenue, cost of sales was 80.7% in Q4 2025, compared to 85.1% in Q4 2024.

Selling, general and administrative (SG&A) expenses were $55.3 million in Q4 2025 compared to $45.1 million in Q4 2024, an increase of $10.2 million or 22.6%. The increase was primarily due to additional headcount and related compensation costs that resulted in lower contracting costs, higher selling expenses related to higher sales volume, foreign exchange losses in Q4 2025 compared to gains in Q4 2024 and a favourable business tax adjustment in a U.S. entity in Q4 2024 that did not recur in Q4 2025. As a percentage of revenue, SG&A expenses were 9.9% in Q4 2025 compared to 8.4% in Q4 2024.

Adjusted EBITDA1 was $84.2 million in Q4 2025 compared to $66.8 million in Q4 2024, an increase of $17.4 million or 26.0%. The increase was primarily due to higher sales volumes and favourable productivity in our manufacturing sites, along with lower pulp costs and freight rates, partially offset by higher manufacturing overhead spend and SG&A expenses.

Net income was $23.4 million in Q4 2025 compared to a net loss of $13.7 million in Q4 2024, an increase of $37.1 million. The increase was primarily due to a foreign exchange difference and higher Adjusted EBITDA1, partially offset by higher income tax expense, higher income from non-controlling interest and higher interest expense and other finance costs.

Kruger Products 2025 Financial Results
Revenue was $2,203.4 million in Fiscal 2025 compared to $2,049.9 million in Fiscal 2024, an increase of $153.5 million or 7.5%. The increase in revenue was primarily due to higher sales volume in the Consumer segment and favourable selling prices across both segments, partially offset by somewhat lower sales volume in the AFH segment from the first half of 2025. Revenue was also favorably impacted by foreign exchange fluctuations on U.S. dollar sales.

Adjusted EBITDA1 was $318.2 million in Fiscal 2025 compared to $264.8 million in Fiscal 2024, an increase of $53.4 million or 20.2%. The increase was primarily due to higher sales volumes and selling prices along with lower pulp prices and favourable manufacturing overhead cost absorption, partially offset by additional manufacturing overhead spend to invest in our sites and unfavourable mill performance at our Memphis site, along with higher warehousing and SG&A expenses.

Net income was $75.5 million in Fiscal 2025 compared to $23.8 million in Fiscal 2024, an improvement of $51.7 million. The improvement was primarily due to higher Adjusted EBITDA1 and a foreign exchange gain, partially offset by higher depreciation expense resulting from the Sherbrooke Expansion Project and a one-time expense related to the restructuring activity in our Memphis site, higher interest expense and other finance costs, higher income from non-controlling interest, higher restructuring costs and higher income tax expense.

Kruger Products Q4 2025 Financing Activity and Liquidity
On December 10, 2025, Kruger Products issued $165 million in an aggregate principal amount of 6.250% Senior Unsecured Notes (the Notes) due December 10, 2032 by way of private placement (the Offering). Interest on the Notes is payable semi-annually in arrears on June 10 and December 10 of each year, commencing on June 10, 2026. A portion of the proceeds were used to fund the repayment in full of the borrowings outstanding under the senior credit facilities of Kruger Products SB Inc. (KPSB) with the balance being used for general corporate purposes. In connection with the Offering, Kruger Products' syndicated credit agreement was amended and restated to, among other things, increase the facility amount from $230 million to $250 million, increase the accordion feature from $75 million to $100 million and add KPSB as a restricted credit party.

Total liquidity, representing cash and availability under the revolving credit agreements, was $451.3 million as of December 31, 2025.

KPT Q4 2025 Financial Results
KPT had net income of $2.6 million in Q4 2025. Included in net income was $2.8 million representing KPT’s share of Kruger Products’ net income, a dilution gain of $0.1 million and depreciation expense of $0.3 million related to adjustments to carrying amounts on acquisition.

KPT 2025 Financial Results
KPT had net income of $8.5 million in Fiscal 2025. Included in net income was $9.2 million representing KPT’s share of Kruger Products’ net income, a dilution gain of $0.4 million and depreciation expense of $1.1 million related to adjustments to carrying amounts on acquisition.

Dividends on Common Shares
The Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on April 15, 2026 to shareholders of record at the close of business on March 31, 2026.

Additional Information
For additional information please refer to Management’s Discussion and Analysis (MD&A) of KPT and Kruger Products for the fourth quarter and fiscal year ended December 31, 2025 available on SEDAR+ at www.sedarplus.ca or our website at www.kptissueinc.com.

Fourth Quarter Results Conference Call Information
KPT will hold its fourth quarter conference call on Wednesday, February 18, 2026 at 8:30 a.m. Eastern Time.
Via telephone: 1-888-699-1199 or 416-945-7677
Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, February 25, 2026 by dialing 1-888-660-6345 or 289-819-1450 and entering passcode 25755.

The replay of the webcast will remain available on the website until midnight, February 25, 2026.

About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12.1% interest in Kruger Products. For more information visit www.kptissueinc.com.

About Kruger Products Inc.
Kruger Products is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. Kruger Products serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®. In the U.S., Kruger Products manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. Kruger Products has approximately 3,000 employees and operates ten FSC® COC-certified (FSC® C-104904) production facilities in North America. For more information visit www.krugerproducts.ca.

Non-GAAP Financial Measures
This press release uses certain non-GAAP financial measures which Kruger Products believes provide useful information to management of Kruger Products and the readers of the financial information in measuring the financial performance and financial condition of Kruger Products. These measures do not have a standardized meaning prescribed by GAAP and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Adjusted EBITDA is not a measurement of operating performance computed in accordance with GAAP and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with GAAP. “Adjusted EBITDA” is calculated by Kruger Products as net income (loss) before (i) interest expense and other finance costs, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) loss on sale of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities and (ix) changes in amortized cost of Partnership units liability. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the Segment and Geographic Results table of this press release.

Forward-Looking Statements
Certain statements in this press release about KPT’s and Kruger Products' current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. Forward-looking statements in this press release include, but are not limited to, items such as plans to build a new TAD tissue plant and its expected annual production capacity, expected date for starting production, the expected financing structure of the project and certain anticipated benefits of the project. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or Kruger Products, including, in respect of the plans to build a new TAD tissue plant, obtaining financing on acceptable terms for the project. Although KPT and Kruger Products believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA1 for Q1 2026 is forward-looking information and is based on the assumptions and subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management’s expectations, at the date of this press release, regarding Kruger Products’ future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.

Many factors could cause Kruger Products’ actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from KPT’s economic interest in Kruger Products) to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the “Risk Factors – Risks Related to Kruger Products’ Business” section of the KPT Annual Information Form dated February 18, 2026 available on SEDAR+ at www.sedarplus.ca (the Annual Information Form): Kruger Inc.’s influence over Kruger Products; Kruger Products’ reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the ownership of the TAD Sherbrooke Project; risks associated with the operation of the TAD Sherbrooke Project; operational risks; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; Kruger Products’ inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of Kruger Products or Kruger Products’ brands; Kruger Products’ sales being less than anticipated; Kruger Products’ failure to implement its business and operating strategies; Kruger Products’ obligation to make regular capital expenditures; Kruger Products entering into unsuccessful acquisitions; Kruger Products’ dependence on key personnel; Kruger Products’ inability to retain its existing customers or obtain new customers; Kruger Products’ loss of key suppliers; Kruger Products’ failure to adequately protect its intellectual property rights; Kruger Products’ reliance on third party intellectual property licenses; adverse litigation and other claims affecting Kruger Products; material expenditures due to comprehensive environmental regulation affecting Kruger Products’ cash flow; Kruger Products’ pension obligations are significant and can be materially higher than predicted if Kruger Products Management’s underlying assumptions are incorrect; labour disputes adversely affecting Kruger Products’ cost structure and Kruger Products’ ability to run its plants; exchange rate and U.S. competitors; Kruger Products’ inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; information technology; cyber-security; insurance; internal controls; trade related and tax.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

INFORMATION:
Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
905-812-6936
[email protected]

INVESTORS:
Doris Grbic
Director, Investor Relations
KP Tissue Inc.
437-882-2596
[email protected]

1 Adjusted EBITDA is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures section of this press release for more information on these measures.

 

 

Kruger Products Inc.

 Consolidated Statements of Financial Position

(thousands of Canadian dollars)

 

 

 

 

 

 

 

 

 

December 31, 2025

 

December 31, 2024

 

 

 

$

 

$

 

 

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

196,094

 

119,460

 

 

Restricted cash

46,070

 

48,375

 

 

Trade and other receivables

143,313

 

138,177

 

 

Receivables from related parties

79

 

80

 

 

Inventories

284,183

 

287,756

 

 

Income tax recoverable

2,963

 

3,208

 

 

Prepaid expenses

5,381

 

6,383

 

 

 

678,083

 

603,439

 

 

Non-current assets

 

 

 

Property, plant and equipment

1,430,206

 

1,509,592

 

 

Right-of-use assets

152,243

 

186,460

 

 

Other long-term assets

-

 

92

 

 

Pensions

91,118

 

92,661

 

 

Goodwill

152,021

 

152,021

 

 

Intangible assets

40,362

 

42,572

 

 

Deferred income taxes

64,671

 

10,500

 

 

Total assets

2,608,704

 

2,597,337

 

 

 

 

 

 

Liabilities

 

 

 

Current liabilities

 

 

 

Trade and other payables

350,831

 

346,264

 

 

Payables to related parties

13,441

 

17,829

 

 

Income tax payable

-

 

3

 

 

Dividends payable

14,853

 

14,308

 

 

Current portion of long-term debt

98,649

 

54,168

 

 

Current portion of lease liabilities

43,576

 

40,156

 

 

Current portion of long-term payable to related party

5,800

 

5,800

 

 

Current portion of provisions

7,283

 

4,184

 

 

 

534,433

 

482,712

 

 

Non-current liabilities

 

 

 

Long-term debt

1,074,148

 

1,180,488

 

 

Long-term lease liabilities

139,694

 

165,563

 

 

Long-term payable to related party

28,064

 

31,925

 

 

Long-term provisions

12,602

 

9,398

 

 

Pensions

17,745

 

17,845

 

 

Post-retirement benefits

48,333

 

47,140

 

 

Deferred income taxes

47,140

 

-

 

 

Total liabilities

1,902,159

 

1,935,071

 

 

 

 

 

 

Equity

 

 

 

Share capital

334,479

 

308,622

 

 

Contributed surplus

395,382

 

395,382

 

 

Deficit

(151,965)

 

(171,874)

 

 

Accumulated other comprehensive income

89,343

 

100,177

 

 

Equity attributable to Kruger Products

667,239

 

632,307

 

 

Non-controlling interest

39,306

 

29,959

 

 

Total equity

706,545

 

662,266

 

 

Total liabilities and equity

2,608,704

 

2,597,337

 

 

 

 

 

 


Kruger Products Inc.

 Consolidated Statements of Income (Loss)

(thousands of Canadian dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

3-month

 

3-month

 

12-month

 

12-month

 

 

period ended

 

period ended

 

period ended

 

period ended

 

 

December 31, 2025

 

December 31, 2024

 

December 31, 2025

 

December 31, 2024

 

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

Revenue

560,056

 

539,621

 

2,203,391

 

2,049,938

 

Expenses

 

 

 

 

 

Cost of sales

451,902

 

459,271

 

1,825,077

 

1,721,704

 

Selling, general and administrative expenses

55,290

 

45,105

 

201,567

 

178,250

 

Restructuring costs

51

 

-

 

3,782

 

219

 

Operating income

52,813

 

35,245

 

172,965

 

149,765

 

Interest expense and other finance costs

23,018

 

21,355

 

86,844

 

72,487

 

Other expense (income)

(4,927

)

24,718

 

(18,375

)

31,870

 

Income (loss) before income taxes

34,722

 

(10,828

)

104,496

 

45,408

 

Current tax expense (recovery)

2,661

 

(415

)

4,711

 

2,734

 

Deferred tax expense

5,652

 

4,956

 

14,926

 

16,679

 

Income tax expense

8,313

 

4,541

 

19,637

 

19,413

 

Net income (loss) including non-controlling interest

26,409

 

(15,369

)

84,859

 

25,995

 

Net income (loss) attributable to non-controlling interest

2,985

 

(1,649

)

9,347

 

2,174

 

Net income (loss) attributable to Kruger Products

23,424

 

(13,720

)

75,512

 

23,821

 

 

 

 

 

 

 


Kruger Products Inc.

 Consolidated Statements of Cash Flows

(thousands of Canadian dollars)

 

 

 

 

 

 

 

 

 

 

 

3-month

 

3-month

 

12-month

 

12-month

 

 

period ended

 

period ended

 

period ended

 

period ended

 

 

December 31, 2025

 

December 31, 2024

 

December 31, 2025

 

December 31, 2024

 

 

$

 

$

 

$

 

$

 

Cash flows from (used in) operating activities

 

 

 

 

Net income (loss) including non-controlling interest

26,409

 

(15,369

)

84,859

 

25,995

 

Items not affecting cash

 

 

 

 

Depreciation

29,434

 

29,105

 

133,309

 

107,793

 

Amortization

1,929

 

2,022

 

8,099

 

6,322

 

Loss on sale of property, plant and equipment

79

 

370

 

74

 

639

 

Loss on disposal of leased assets

65

 

47

 

88

 

47

 

Foreign exchange loss (gain)

(4,927

)

24,719

 

(18,375

)

32,752

 

Interest expense and other finance costs

23,018

 

21,355

 

86,844

 

72,487

 

Pension and post-retirement benefits

2,853

 

3,328

 

11,270

 

12,292

 

Provisions

2,287

 

1,464

 

8,146

 

4,879

 

Income tax expense

8,313

 

4,541

 

19,637

 

19,413

 

Loss on sale of non-financial assets

-

 

18

 

-

 

45

 

Total items not affecting cash

63,051

 

86,969

 

249,092

 

256,669

 

Net change in non-cash working capital

35,002

 

(5,630

)

5,532

 

(58,604

)

Contributions to pension and post-retirement benefit plans

(686

)

(1,058

)

(3,570

)

(4,476

)

Provisions paid

-

 

-

 

(4,679

)

(3,695

)

Income tax payments, net

233

 

(665

)

(2,259

)

(3,786

)

Net cash from operating activities

124,009

 

64,247

 

328,975

 

212,103

 

 

 

 

 

 

Cash flows from (used in) investing activities

 

 

 

 

Purchases of property, plant and equipment

(29,157

)

(28,941

)

(52,470

)

(44,762

)

Purchases of property, plant and equipment related to the
     Sherbrooke Expansion Project

(1,344

)

(13,511

)

(20,517

)

(129,678

)

Interest paid on credit facilities related to the
     Sherbrooke Expansion Project

-

 

(2,628

)

-

 

(7,764

)

Government assistance received

1,000

 

-

 

4,119

 

-

 

Purchases of software

(2,900

)

(2,978

)

(4,983

)

(3,272

)

Proceeds on sale of property, plant and equipment

339

 

-

 

339

 

28

 

Net cash used in investing activities

(32,062

)

(48,058

)

(73,512

)

(185,448

)

 

 

 

 

 

Cash flows from (used in) financing activities

 

 

 

 

Proceeds from long-term debt

165,000

 

160,156

 

174,171

 

279,353

 

Repayment of long-term debt

(166,517

)

(130,770

)

(215,635

)

(163,815

)

Payment of deferred financing fees

(3,561

)

(3,181

)

(3,584

)

(4,493

)

Payment of lease liabilities

(9,634

)

(9,736

)

(35,109

)

(36,199

)

Change in restricted cash

(1,425

)

(3,543

)

2,305

 

(35,924

)

Interest paid on long-term debt

(19,797

)

(15,839

)

(61,193

)

(54,678

)

Payment to related party

-

 

-

 

(5,800

)

(5,800

)

Dividends paid

(14,726

)

(14,173

)

(58,079

)

(55,806

)

Proceeds from issuing partnership units

6,529

 

6,248

 

25,676

 

30,456

 

Net cash used in financing activities

(44,131

)

(10,838

)

(177,248

)

(46,906

)

Effect of exchange rate changes on cash and cash equivalents
     held in foreign currency

(853

)

2,894

 

(1,581

)

3,983

 

Increase (Decrease) in cash and cash equivalents during
     the year

46,963

 

8,245

 

76,634

 

(16,268

)

Cash and cash equivalents - Beginning of year

149,131

 

111,215

 

119,460

 

135,728

 

Cash and cash equivalents - End of year

196,094

 

119,460

 

196,094

 

119,460

 

 

 

 

 

 

 

 

 

 

 


Kruger Products Inc.

Segment and Geographic Results

(thousands of Canadian dollars)

 

 

 

 

 

 

 

 

 

 

 

3-month

 

3-month

 

12-month

 

12-month

 

 

period ended

 

period ended

 

period ended

 

period ended

 

 

December 31, 2025

 

December 31, 2024

 

December 31, 2025

 

December 31, 2024

 

 

$

 

$

 

$

 

$

 

Segment Information

 

 

 

 

 

 

 

 

 

Segment Revenue

 

 

 

 

Consumer

472,286

 

452,709

 

1,855,011

 

1,708,119

 

AFH

87,770

 

86,912

 

348,380

 

341,819

 

Revenue from external customers

560,056

 

539,621

 

2,203,391

 

2,049,938

 

 

 

 

 

 

Other segment items

 

 

 

 

Consumer

394,156

 

388,737

 

1,553,401

 

1,458,774

 

AFH

78,052

 

82,293

 

316,531

 

313,259

 

Corporate and other costs

3,565

 

1,831

 

15,230

 

13,122

 

Total other segment items

475,773

 

472,861

 

1,885,162

 

1,785,155

 

 

 

 

 

 

Adjusted EBITDA

 

 

 

 

Consumer

78,130

 

63,972

 

301,610

 

249,345

 

AFH

9,718

 

4,619

 

31,849

 

28,560

 

Corporate and other costs

(3,565

)

(1,831

)

(15,230

)

(13,122

)

Total Adjusted EBITDA

84,283

 

66,760

 

318,229

 

264,783

 

 

 

 

 

 

Reconciliation to net income (loss)

 

 

 

 

Depreciation and amortization

31,363

 

31,127

 

141,408

 

114,115

 

Interest expense and other finance costs

23,018

 

21,355

 

86,844

 

72,487

 

Loss on disposal of property, plant and equipment

56

 

370

 

74

 

639

 

Loss on sale of non-financial assets

-

 

18

 

-

 

45

 

Change in amortized cost of Partnership units liability

-

 

-

 

-

 

(882

)

Restructuring costs, net

51

 

-

 

3,782

 

219

 

Foreign exchange loss (gain)

(4,927

)

24,718

 

(18,375

)

32,752

 

Income (loss) before income taxes

34,722

 

(10,828

)

104,496

 

45,408

 

Income tax expense

8,313

 

4,541

 

19,637

 

19,413

 

Net income (loss) including non-controlling interest

26,409

 

(15,369

)

84,859

 

25,995

 

 

 

 

 

 

Geographic Revenue

 

 

 

 

 

 

 

 

 

Canada

306,368

 

291,391

 

1,195,585

 

1,118,754

 

US

253,688

 

248,230

 

1,007,806

 

931,184

 

Total revenue

560,056

 

539,621

 

2,203,391

 

2,049,938

 

 

 

 

 

 


KP Tissue Inc.

Statements of Financial Position

(thousands of Canadian dollars)

 

 

 

 

 

 

 

December 31, 2025

December 31, 2024

 

$

$

Assets

 

 

Current assets

 

 

Dividends receivable

1,803

1,798

 

1,803

1,798

Non-current assets

 

 

Investment in associate

69,799

69,517

Total assets

71,602

71,315

 

 

 

Liabilities

 

 

Current liabilities

 

 

Dividend payable

1,803

1,798

Total liabilities

1,803

1,798

 

 

 

Equity

 

 

Common Shares

23,001

22,762

Contributed surplus

144,819

144,819

Deficit

(114,985)

(116,673)

Accumulated other comprehensive income

16,964

18,609

Total equity

69,799

69,517

Total liabilities and equity

71,602

71,315

 

 

 


KP Tissue Inc.

Statements of Income (Loss)

(thousands of Canadian dollars, except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

 

3-month

 

3-month

 

12-month

 

12-month

 

 

period ended

 

period ended

 

period ended

 

period ended

 

 

December 31, 2025

 

December 31, 2024

 

December 31, 2025

 

December 31, 2024

 

 

$

 

$

 

$

 

$

 

Share of income (loss)

2,793

 

(1,765

)

9,165

 

2,993

 

Depreciation of fair value increments

(267

)

(276

)

(1,094

)

(1,123

)

Equity income (loss)

2,526

 

(2,041

)

8,071

 

1,870

 

Dilution gain

110

 

119

 

433

 

619

 

Income (loss) before income taxes

2,636

 

(1,922

)

8,504

 

2,489

 

Current tax expense

-

 

56

 

-

 

56

 

Income tax expense

-

 

56

 

-

 

56

 

Net income (loss)

2,636

 

(1,978

)

8,504

 

2,433

 

Basic earning (loss) per share

0.26

 

(0.20

)

0.85

 

0.24

 

Weighted average number of shares outstanding

10,014,269

 

9,986,446

 

10,003,661

 

9,976,725

 

 

 

 

 

 


KP Tissue Inc.

Statements of Cash Flows

(thousands of Canadian dollars)

 

 

 

 

 

 

 

 

 

 

 

3-month

 

3-month

 

12-month

 

12-month

 

 

period ended

 

period ended

 

period ended

 

period ended

 

 

December 31, 2025

 

December 31, 2024

 

December 31, 2025

 

December 31, 2024

 

 

$

 

$

 

$

 

$

 

Cash flows from (used in) operating activities

 

 

 

 

Net income (loss)

2,636

 

(1,978

)

8,504

 

2,433

 

Items not affecting cash

 

 

 

 

Equity income (loss)

(2,526

)

2,041

 

(8,071

)

(1,870

)

Dilution gain

(110

)

(119

)

(433

)

(619

)

Current tax expense

-

 

56

 

-

 

56

 

Total items not affecting cash

(2,636

)

1,978

 

(8,504

)

(2,433

)

Decrease (increase) in payable to investee

-

 

65

 

-

 

(595

)

Tax refunds, net

-

 

(65

)

-

 

595

 

Net cash from operating activities

-

 

-

 

-

 

-

 

 

 

 

 

 

Cash flows from (used in) investing activities

 

 

 

 

Dividends received, net

1,734

 

1,735

 

6,963

 

6,974

 

Net cash from investing activities

1,734

 

1,735

 

6,963

 

6,974

 

 

 

 

 

 

Cash flows from (used in) financing activities

 

 

 

 

Dividends paid, net

(1,734

)

(1,735

)

(6,963

)

(6,974

)

Net cash used in financing activities

(1,734

)

(1,735

)

(6,963

)

(6,974

)

Increase in cash and cash equivalents during the year

-

 

-

 

-

 

-

 

Cash and cash equivalents - Beginning of year

-

 

-

 

-

 

-

 

Cash and cash equivalents - End of year

-

 

-

 

-

 

-